Latest Breaking News On - Orphan product development - Page 5 : comparemela.com

Aquestive Therapeutics, Inc (AQST) Q1 2022 Earnings Call Transcript

AQST earnings call for the period ending March 31, 2022.

United statesAquestive libervantGary nachmanBennett watsonKeith kendallErnie tothLincoln park capital fundSecurities exchange commission onProduct developmentAquestive therapeutics incAquestive therapeuticsRisk factorsSecurities exchange commissionChief executiveOrphan product developmentLincoln park

Aquestive Therapeutics, Inc (AQST) Q1 2022 Earnings Call Transcript

AQST earnings call for the period ending March 31, 2022.

United statesJason butlerAndreas argyridesThomas flatenGary nachmanKeith kendallErnie tothDan barberAndreas argyrides wedbushRam selvarajuAquestive libervantBennett watsonLincoln park capital fundSecurities exchange commission onProduct developmentCompany analyst

Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesStephanie carringtonKeith kendallSecurities exchange commissionHaisco pharmaceutical group co ltdDrug administrationOffice of orphan product developmentAquestive therapeutics incLincoln park capital fundDevelopment expenseDevelopment expense to adjusted researchWall streetChief executive officerOrphan product developmentLincoln park capitalUnited states food

Aquestive Therapeutics Inc (AQST) Reports Q1, Provides Business Update

Aquestive Therapeutics Inc (AQST) Reports Q1, Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWestwickestephanie carringtonKeith kendallAquestive therapeuticsaquestive therapeutics incDevelopment expense in thousands unauditedSecurities exchange commissionHaisco pharmaceutical group co ltdDrug administrationOffice of orphan product developmentAquestive therapeutics incDevelopment expenseLincoln park capital fundWebcast reminderthe companyDevelopment expense to adjusted researchChief executive officerOrphan product development